Patent details

300791 Product Name: Isavuconazol als isavuconazonium sulfaat of als een isavuconazonium zout met elk ander farmaceutisch aanvaardbaar anion, naar keuze in de vorm van een farmaceutisch aanvaardbaar zout, hydraat of solvaat

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300791
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1280795
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300791
Procedural language:
Dutch
First Applicant Residence Country:
Switzerland (CH)

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1036
Marketing Authorization Type:
EEA
Marketing Authorization Date:
19/10/2015
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
26/01/2016
First Marketing Authorization date:
19/10/2015
Grant date:
15/03/2016
Activation date:
25/10/2020
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
12/02/2016
SPC/SPC Extension Expiration Date:
24/10/2025
Lapsed By Expiration Date:
25/10/2025
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
23/05/2023
 
 

 

Name:
Basilea Pharmaceutica International AG, Allschwil
Address:
Hegenheimermattweg 167b, 4123, Allschwil, Switzerland (CH)

Historical Applicant/holder

From:
26/01/2016
To:
23/05/2023

 

Name:
Basilea Pharmaceutica International Ltd.
Address:
Grenzacherstrasse 487, 4058, BASEL, Switzerland (CH)

Agent

Name:
ir. J.C. Volmer c.s.
From:
10/02/2016
Address:
Exter Polak & Charlouis B.V. Postbus 3241, 2280 GE, Rijswijk, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
44/25
Publication date:
29/10/2025
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
23/23
Publication date:
07/06/2023
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
SPC
Journal edition number:
44/20
Publication date:
28/10/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

4

Bulletin Heading:
SPC
Journal edition number:
11/16
Publication date:
16/03/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

5

Bulletin Heading:
SPC
Journal edition number:
07/16
Publication date:
17/02/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of Legal Entity
Deed Number:
RC202301034A
Date Registered:
23/05/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. J.C. Volmer c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Basilea Pharmaceutica International AG, Allschwil
Address:
Hegenheimermattweg 167b, 4123, Allschwil, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Other

Note:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
06/09/2024
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
2400 Euro
Payer:
Patrix IP Services
Filing date Document type Document Description Number of pages File Type
15/03/2016 SPC Documents Certificate SPC 1 PDF /2/8/5/0/3/0800030582/docs/300791_7_supplprotectioncertificate20201215031008368.pdf
15/03/2016 Outgoing Correspondence Decision grant 2 PDF /2/8/5/0/3/0800030582/docs/300791_10_outgoingcorrespondence20201215031008281.pdf
12/02/2016 Outgoing Correspondence Confirmation receipt request 1 PDF /2/8/5/0/3/0800030582/docs/300791_3_outgoingcorrespondence20201215030712137.pdf
26/01/2016 Payment Order Dossier Payment Order 1 PDF /2/8/5/0/3/0800030582/docs/300791_0_paymentorderdossier20160210020705418.pdf
26/01/2016 Application Form First filed application form 2 PDF /2/8/5/0/3/0800030582/docs/300791_1_applicationform20160210020705362.pdf
26/01/2016 SPC Documents Annex SPC 22 PDF /2/8/5/0/3/0800030582/docs/300791_2_supplprotectioncertificate20201215025742121.pdf
26/01/2016 SPC Documents Annex SPC 41 PDF /2/8/5/0/3/0800030582/docs/300791_4_supplprotectioncertificate20201215025741974.pdf
26/01/2016 SPC Documents Annex SPC 1 PDF /2/8/5/0/3/0800030582/docs/300791_5_supplprotectioncertificate20201215023216274.pdf
26/01/2016 SPC Documents Annex SPC 6 PDF /2/8/5/0/3/0800030582/docs/300791_6_supplprotectioncertificate20201215030354850.pdf
26/01/2016 SPC Documents Accompanying letter SPC 2 PDF /2/8/5/0/3/0800030582/docs/300791_8_supplprotectioncertificate20201215030548034.pdf
26/01/2016 SPC Documents Annex SPC 22 PDF /2/8/5/0/3/0800030582/docs/300791_9_supplprotectioncertificate20201215022801194.pdf
26/01/2016 SPC Documents Marketing Authorization SPC 5 PDF /2/8/5/0/3/0800030582/docs/300791_11_supplprotectioncertificate20201215025741874.pdf
26/01/2016 SPC Documents Annex SPC 2 PDF /2/8/5/0/3/0800030582/docs/300791_12_supplprotectioncertificate20201215025742046.pdf
26/01/2016 SPC Documents Annex SPC 2 PDF /2/8/5/0/3/0800030582/docs/300791_13_supplprotectioncertificate20201215022801136.pdf
26/01/2016 SPC Documents Summary of the characteristics of the product 42 PDF /2/8/5/0/3/0800030582/docs/300791_14_supplprotectioncertificate20201215022801048.pdf